Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E N Jonsson

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Annals of the Rheumatic Diseases|May 19, 2006
Diurnal variation in serum levels of cartilage oligomeric matrix protein in patients with knee osteoarthritis or rheumatoid arthritisM L E Andersson, I F Petersson, K E Karlsson, et al.
Clinical Pharmacology and Therapeutics|February 16, 2007
A PK-PD model for predicting the impact of age, CYP2C9, and VKORC1 genotype on individualization of warfarin therapyA-K Hamberg, M-L Dahl, M Barban, et al.
Clinical Pharmacology and Therapeutics|April 23, 2010
A pharmacometric model describing the relationship between warfarin dose and INR response with respect to variations in CYP2C9, VKORC1, and ageA-K Hamberg, M Wadelius, J D Lindh, et al.
Clinical Pharmacology and Therapeutics|May 14, 2010
A comprehensive hepatitis C viral kinetic model explaining cureE Snoeck, P Chanu, M Lavielle, et al.
Bone Marrow Transplantation|November 13, 2001
Population pharmacokinetic analysis resulting in a tool for dose individualization of busulphan in bone marrow transplantation recipientsM Sandström, M O Karlsson, P Ljungman, et al.
British Journal of Clinical Pharmacology|May 13, 1998
Artemisinin population pharmacokinetics in children and adults with uncomplicated falciparum malariaJ S Sidhu, M Ashton, N V Huong, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Annals of the Rheumatic Diseases|May 19, 2006
Diurnal variation in serum levels of cartilage oligomeric matrix protein in patients with knee osteoarthritis or rheumatoid arthritisM L E Andersson, I F Petersson, K E Karlsson, et al.
Clinical Pharmacology and Therapeutics|February 16, 2007
A PK-PD model for predicting the impact of age, CYP2C9, and VKORC1 genotype on individualization of warfarin therapyA-K Hamberg, M-L Dahl, M Barban, et al.
Clinical Pharmacology and Therapeutics|April 23, 2010
A pharmacometric model describing the relationship between warfarin dose and INR response with respect to variations in CYP2C9, VKORC1, and ageA-K Hamberg, M Wadelius, J D Lindh, et al.
Clinical Pharmacology and Therapeutics|May 14, 2010
A comprehensive hepatitis C viral kinetic model explaining cureE Snoeck, P Chanu, M Lavielle, et al.
Bone Marrow Transplantation|November 13, 2001
Population pharmacokinetic analysis resulting in a tool for dose individualization of busulphan in bone marrow transplantation recipientsM Sandström, M O Karlsson, P Ljungman, et al.
British Journal of Clinical Pharmacology|May 13, 1998
Artemisinin population pharmacokinetics in children and adults with uncomplicated falciparum malariaJ S Sidhu, M Ashton, N V Huong, et al.
Pageof 2